NCT06741657View on ClinicalTrials.gov

A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways

PHASE1RecruitingINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

April 8, 2026

Study Completion Date

April 8, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

Litifilimab

Administered as specified in the treatment arm.

DEVICE

AI

Administered as specified in the treatment arm.

DEVICE

OBI

Administered as specified in the treatment arm.

DEVICE

PFS

Administered as specified in the treatment arm.

Trial Locations (2)

78744

RECRUITING

Austin Clinical Research Unit, Austin

89113

RECRUITING

Las Vegas Clinical Research Unit, Las Vegas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT06741657 - A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways | Biotech Hunter | Biotech Hunter